← Open Payments lookup

ROSEMARY MELESKO: Open Payments

NPI 1609120435 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,483 in 24 payments from 17 companies in 2025. Trend: 2023 $2,660 · 2024 $1,850 · 2025 $2,483

Food & beverage: $2,483
CompanyPaymentsAmount
GlaxoSmithKline, LLC.3$333
ABIOMED2$263
ABBVIE INC.2$250
Axsome Therapeutics, Inc.2$241
Biogen, Inc.2$208
AtriCure, Inc.2$207
Gilead Sciences, Inc.1$137
Teva Pharmaceuticals USA, Inc.1$130
Vanda Pharmaceuticals Inc.1$125
Ultragenyx Pharmaceutical Inc.1$122

Products named: VRAYLAR, Auvelity, SYNERGY ABLATION SYSTEM, Yeztugo, AUSTEDO XR, FANAPT, Dojolvi, KRYSTEXXA.

Industry payments across CA — which companies pay providers there.